SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ChiRex (CHRX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yosi s who wrote (95)1/22/1998 1:10:00 AM
From: m meixlER  Read Replies (1) of 130
 
dont have a # for the playback--the book at 92m shows what chirex
paid minus depreciation--acc w the analyistat first bost the market value of the 2 manuf facilities is approx 220 million (there is no way for
me to confim that--it sounds reasonable though looking at the sizes==
i dont think you can compare chirex to sepr as sepr is a biotech and
chirex is more of a high tech contract pharmacutical manufacturer--I
dont think there are many public comparibles for this co to compare to ( if any)----i do think the upside is huge though--we are in the first inning of the big drug co's efforts to outsource production--i think chirex is well positioned
and once they have there manufacturing production probs solved
there will be huge upsides to earnings in about 18 months---At this point--though in regards to the investment comm---the co promised on delivering big eps quicker and the mkt is disapointed--they didnt see the production snafus. If you look at price to 98 proj rev and eps as
well as book --i think the stock is dirt cheap for this kind of potentail--
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext